Goto

Collaborating Authors

Pharma 4.0 and the pharmaceutical engineering industry of the future - Express Pharma

#artificialintelligence

Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.


Pharma 4.0 and the pharmaceutical engineering industry of the future - Express Pharma

#artificialintelligence

Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.


Trade Pharma Network: A Pharma-centric Marketplace • Newbium

#artificialintelligence

As a consumer, you probably won't take an interest in knowing how medicines end up in drug stores. As long as they're available when you need them, the ins and outs of pharmaceutical supplies are the least of your concern. But you should be concerned because you're not supposed to pay a high price for the medicines that you are enjoying now. Drugs and medicines actually go through so many agents before they reach the hands of the consumers, and this, coupled with trade restrictions, limits access to cheap medicines and only increases the cost by not less than 100%. Imagine how much you would have saved if these medicines were passed on directly to you, and not through layers of intermediaries.


[BOUNTY] Trade Pharma Network The New Pharma-Centric Marketplace -- #REOPENED

#artificialintelligence

As planned the Trade Pharma Network bounty campaign is reopened now. Thus, week 5 starts on September 26th 2018. Trade Pharma Network is a EU-licensed brokerage platform and an international pharma-centric marketplace of choice for buyers & sellers performing their routine transactions of medicines. Our Artificial Intelligence (AI) driven platform uses powerful AI algorithms to enable efficient search & digital matchmaking between our key stakeholders but also Blockchain as we envision a future where every physical medicine has a digital history, allowing our users to trace and verify its origins, attributes and ownership to fight efficiently against counterfeit medicines, in Europe & Worldwide. We are also providing a full suite of services that facilitate information exchange, communication and transactions between pharma & healthcare users.


Precision Oncology Company Lantern Pharma to Showcase Artificial Intelligence Approach

#artificialintelligence

NEW YORK--(BUSINESS WIRE)--Lantern Pharma is applying Artificial Intelligence (AI) to tailor multiple promising precision drug programs to the right cancer patients through use of their RADRTM platform (Response Algorithm for Drug Rescue and Positioning). Lantern is disrupting the drug development process using seamless integration of relevant existing data, generation of new clean data closely modeling real world evidence and very focused AI technology application to further model this data and distill into meaningful information that can identify & stratify right patients with high accuracy. Even a small step ahead in the right direction will be a huge leap for the pharma industry. Lantern is currently leading the way in AI directed drug development, recently having fast tracked shelved assets from in-license to out-license within 18 months. Lantern is currently progressing 3 clinical stage drugs in using this technology.